Viewing Study NCT03482557


Ignite Creation Date: 2025-12-24 @ 6:38 PM
Ignite Modification Date: 2026-01-05 @ 6:32 PM
Study NCT ID: NCT03482557
Status: COMPLETED
Last Update Posted: 2025-01-09
First Post: 2018-03-23
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Contrast Enhanced Spectral Mammography vs. MRI for Breast Cancer Screening
Sponsor: Beth Israel Deaconess Medical Center
Organization:

Study Overview

Official Title: Contrast Enhanced Spectral Mammography vs. MRI for Breast Cancer Screening
Status: COMPLETED
Status Verified Date: 2025-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This research study is evaluating whether contrast enhanced mammography can be used as an alternative to breast Magnetic Resonance Imaging (MRI) for cancer screening
Detailed Description: Mammography is the main way to help find breast cancers early so they can be treated. Unfortunately, mammography does not work as well in women who have dense breast tissue or who are at high-risk for breast cancer. In these women, breast MRI is also used to help find breast cancers.

Contrast enhanced mammography is a new type of mammogram. It uses contrast material combined with the mammogram to highlight areas that might be breast cancer and that could be missed on the mammogram alone. This is similar to breast MRI.

For this study, participants who had both CEM and MRI evaluating a finding that initiated from a screening exam will be included. Radiologists will compare the images to see if the contrast enhanced mammograms and the breast MRI find the same number of breast cancers. If the investigators find they perform similarly, then contrast mammography may be used to aid in breast cancer screening in the future.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: True
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: